Kristen Fiore, PhD
Related Posts
Outsourcing Peptide Synthesis: What Drug Discovery Teams Should Know Before Choosing a CRO
Every drug discovery program built on peptide therapeutics eventually runs into the same wall: you need a compound you can’t make in-house, on a...
Branched Peptides vs. Mini Proteins: Choosing the Right Modality for Your Target
Every peptide drug design program eventually hits the same fork: the linear sequence won’t get you the potency, stability, or selectivity you...
The Synthesis Gap: Why the Distance Between Peptide Design and Peptide Manufacturing Is the Biggest Bottleneck in Drug Discovery
Introduction There is a particular kind of frustration that runs through modern peptide drug discovery programs, one that does not show up cleanly...